Zimmer Biomet Holdings Inc (NYSE:ZBH)
| 126.88 Delayed Data As of Sep 26 |  -1.45 / -1.13%Today’s Change | 88.27 Today|||52-Week Range 133.19 | +23.68% Year-to-Date |
Latest ZBH News | Press Releases
| Zimmer Biomet Introduces Vanguard Individualized Design Sep 21 / Zacks.com - Paid Partner Content | Zimmer Biomet Buys Clinical Graphics, Boosts Hip Business Sep 16 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 128.33 |
| Today’s open | 127.60 |
| Day’s range | 126.76 - 127.81 |
| Volume | 590,453 |
| Average volume (3 months) | 1,487,286 |
| Market cap | $25.7B |
| Dividend yield | 0.76% |
Data as of 09/26/2016
Growth & Valuation
| Earnings growth (last year) | -81.62% |
| Earnings growth (this year) | +15.51% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +28.34% |
| P/E ratio | 109.4 |
| Price/Sales | 3.25 |
| Price/Book | 2.63 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BSXBoston Scientific Co... | +0.02 | +0.08% |
| BCRC R Bard Inc | -2.02 | -0.88% |
| BDXBecton Dickinson and... | -2.49 | -1.39% |
| DXCMDexCom Inc | -0.75 | -0.80% |
Data as of 09/26/2016
Financials
| Next reporting date | October 20, 2016 |
| EPS forecast (this quarter) | $1.79 |
| Annual revenue (last year) | $6.0B |
| Annual profit (last year) | $147.0M |
| Net profit margin | 2.45% |
Profile
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director David C. Dvorak |
Senior VP-Global Operations & Logistics Robin T. Barney |
Corporate headquarters Warsaw, Indiana |
Forecasts
